Boardroom Alpha
Start trial
Research library
SPACs · Aug 26, 2026

SPAC Market Update August 26, 2026: JTTT Prices $60M IPO, FVN Extension Approved

JATT III Acquisition Corp (JTTT) priced a $60M SPAC IPO on August 26, 2026. Separately, Future Vision II Acquisition Corp (FVN) approved an extension to September 13, 2027 after 1,866,403 shares were redeemed.

SPAC IPO Update — August 26, 2026

1 SPAC IPO priced on August 26, 2026, raising $60M; August MTD now stands at 9 IPOs totaling $1.30B over 26 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 9•Prior: 18•MoM: -9
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
9
Aug ’26
Source: Boardroom Alpha
IPO Activity Snapshot1 SPAC IPO today raising $60M · JTTT ($60M)
Month-to-date: 9 IPOs ($1.30B) vs. first 26 days of last month 15 ($3.26B) · 12-mo avg: 17/mo
$ totals include underwriter over-allotment.
Size
$60M
Ticker
Sponsor
JATT Ventures III L.P.

Jatt III Acquisition Corp. is targeting the life sciences sector, leveraging its team’s experience in sourcing, structuring, financing, and growing biopharmaceutical businesses. The SPAC aims to identify businesses with rigorous science, compelling data, and a potential for significant value creation.

Leadership
Arjun GoyalDirector
Founder and Managing Partner of Vianti Capital; co-founded Vida Ventures with multiple successful exits including Pionyr Immunotherapeutics and Peloton Therapeutics.
Christopher StaralDirector
Founder and CIO of Triple Helix Investments; previously led biotech strategies at Laurion Capital Management.
Jonathon KluftDirector
Consultant to Atika Capital Management; previously VP at Roivant Sciences, involved in forming subsidiaries like Immunovant and Urovant.
Nicholas FernandezCFO
Former CFO of Jefferies LLC’s Asset Management division and current CFO at Amanat Acquisition Corp.
Someit SidhuCEO, Director
Founder of Khanda Therapeutics and co-founder of Izana Bioscience; former McKinsey consultant in Pharmaceutical R&D.
Verender S BadialDirector
Managing Director of Cryfield Investments; former CFO of Zura Bio Limited and experienced in equity capital markets.

Structure: 6,000,000 ordinary shares at $10.00 each. Guggenheim Securities, LLC is the sole book-runner.

New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Aug 26 JTTT JATT III Acquisition Corp $60M 100.0%
Aug 18 XTER KARMAN LINE ACQUISITION CORP $200M 100.0%
Aug 18 NSAI NORTHSTRIVE ACQUISITION CORP I $100M 100.0%
Source: Boardroom Alpha

Daily SPAC Update — August 26, 2026

SPAC VOTE RESULTS
FUTURE VISION II ACQUISITION CORP (FVN) * Extend to September 13, 20271,866,403 redeemed

SPAC DEALS ANNOUNCED
August 25 | Bleichroeder Acquisition Corp III (BCCQ) + URSA MAJOR TECHNOLOGIES, INC.Ursa Major Technologies, Inc. is an aerospace and defense company that develops hypersonics, solid rocket motors, and space mobility systems. It is headquartered in Berthoud, Colorado, with additive manufacturing operations in Youngstown, Ohio. The company focuses on producing systems for various domains, including land, air, sea, and space, aiming to enhance the defense industrial base for the U.S. and its allies.
August 22 | Starry Sea Acquisition Corp (SSEA) + SuperiorMed Holdings LimitedSuperiorMed Holdings Limited is a Cayman-incorporated holding company that operates a healthcare management and services platform based in Dubai. Its core business includes longevity medicine, wellness services, and health tourism. Through its subsidiary, SuperiorMed Healthcare Management FZ-LLC, it manages clinic and wellness facility operations, patient referral coordination, and health tourism programs, including hotel-integrated retreats.

SPAC DEAL & EXTENSION VOTES SET
Hudson Acquisition I Corp (HUDA) * DEAL VOTE SET: September 14, 2026 * trust $11.03
Winvest Acquisition Corp (WINV) * EXTENSION VOTE SET: September 15, 2026 * trust $15.16

SPAC EXTENSIONS
DT CLOUD STAR ACQUISITION CORP (DTSQ) * Extension FilingDT Cloud Star extends initial business combination deadline to August 26, 2026 via Trust Account deposits.
BLACK HAWK ACQUISITION CORP (BKHA) * Extension FilingBlack Hawk extends initial business combination deadline to Sept 22, 2026 after depositing $150,000 into the trust.

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-08-20: CEPO + BSTR, Holdings Inc.

SEPARATE WARRANTS/RIGHTS
August 24: MERIDIAN3 INDUSTRIALS ACQUISITION CORP (MIAC)

OTHER SPAC NEWS
BLEICHROEDER ACQUISITION CORP III (BCCQ) * Merger Agreement
BLEICHROEDER ACQUISITION CORP III (BCCQ) * Investor Deck
BLEICHROEDER ACQUISITION CORP III (BCCQ) * Media TranscriptUrsa Major will merge with Inflection Point Mach 10 to become a public company. Closing is expected in Q1 2027.

SPAC LISTING RULE NOTICES
AIMEI HEALTH TECHNOLOGY CO LTD (AFJK) * Listing Rule NoticeNasdaq notices MVLS and MVPHS deficiencies; 180-day cure periods to regain compliance, with potential delisting.
BEST SPAC I ACQUISITION CORP (BSAA) * Listing Rule NoticeNasdaq flagged MVLS below threshold; 180-day window to regain compliance; delisting possible; company may appeal.
QUARTZSEA ACQUISITION CORP (QSEA) * Listing Rule NoticeQuartzsea paid the $75,000 overdue Nasdaq fee; no confirmation of withdrawal yet; no hearing requested.

SPAC LIQUIDATIONS
ARTIUS II ACQUISITION INC (AACB) -> Liquidation on August 19

SPAC Executive & Director Moves — August 26, 2026

SPAC Executive & Director Moves
Company Ticker Moves
BLEICHROEDER ACQUISITION CORP III BCCQ
  • Effective August 24, 2026, Michael Blitzer was appointed as Chairman of the Board and Kevin Shannon as Co-Chief Executive Officer of Mach X, while Andrew Gundlach and Marcello Padula continue as director and Co-Chief Executive Officer, respectively.  (view source)
CANTOR EQUITY PARTNERS IV INC CEPF
  • Dr. Mukesh Prasad has been appointed as a member of the Board of Cantor Equity Partners IV, Inc. and will also serve on the audit and compensation committees, effective August 25, 2026.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — August 26, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
HENNESSY CAPITAL INVESTMENT CORP VII HVII 12.5% $ 7.84 Announced
RESEARCH ALLIANCE CORP IV RACD 4.8% $ 12.90 Pre-Deal
RESEARCH ALLIANCE CORP III RACC 4.5% $ 22.00 Announced
CHURCHILL CAPITAL CORP XI CCXI 2.6% $ 14.45 Announced
AIMEI HEALTH TECHNOLOGY CO LTD AFJK 2.2% $ 12.28 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
FUTURE VISION II ACQUISITION CORP FVN -52.5% $ 9.43 Announced
GENERAL PURPOSE ACQUISITION CORP GPAC -29.1% $ 7.92 Pre-Deal
KEEN VISION ACQUISITION CORP KVAC -13.1% $ 11.51 Announced
RISING DRAGON ACQUISITION CORP RDAC -11.3% $ 5.32 Announced
ASPAC III ACQUISITION CORP ASPC -4.9% $ 10.95 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • How many SPAC IPOs priced in August 2026 through August 26?
    9 SPAC IPOs priced for $1.30B through August 26, 2026, compared with 15 IPOs for $3.26B over the same span in July 2026.
  • What sector is JATT III Acquisition Corp targeting?
    JATT III Acquisition Corp (JTTT) is targeting the life sciences sector, with a focus on biopharmaceutical businesses backed by rigorous science and compelling data.
  • What happened at Future Vision II Acquisition Corp’s extension vote?
    Future Vision II Acquisition Corp (FVN) received approval to extend its deadline to September 13, 2027, with 1,866,403 shares redeemed.
  • When is Hudson Acquisition I Corp’s deal vote scheduled?
    Hudson Acquisition I Corp (HUDA) scheduled its deal vote for September 14, 2026.
  • Which SPAC scheduled an extension vote today?
    Winvest Acquisition Corp (WINV) set an extension vote for September 15, 2026.


Go deeper

SPAC data & trackers

Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Aug 26, 2026

More from SPACs

All research
SPACs · Oct 15, 2026

SPAC Market Update October 15, 2026: ATII-Forge Nano Vote, OACC Redemption Update

Archimedes Tech Spac Partners Ii Co (ATII) held its Forge Nano, Inc. merger vote on October 15, 2026; no transaction dollar value was disclosed. Forge Nano develops proprietary…

Read
SPACs · Oct 14, 2026

SPAC Market Update October 14, 2026: Frazier Life Sciences II $75M IPO, COPL / Ignite Proteomics Deal Termination

Frazier Life Sciences Acquisition Corp. II (FLSC) priced a $75M IPO on October 14, 2026, targeting therapeutics and other life sciences assets. Frazier Life Sciences Holdings II…

Read
SPACs · Oct 13, 2026

SPAC Market Update October 13, 2026: Blackhawk + Vesicor Deal Vote, IX Acquisition Extension Approved

Black Hawk Acquisition Corp (BKHA) held its Vesicor Therapeutics, Inc. merger vote on October 13, 2026; no transaction dollar value was disclosed. Separately, IX Acquisition Corp…

Read
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer